Cutaneous T-cell lymphoma is a rare cancer ... for the condition. In the study, 69 patients with cutaneous T-cell lymphoma, including the most common subtypes mycosis fungoides and Sézary ...

Drug coverage for four drugs used to treat some rare diseases was announced in Fredericton ... New Brunswick chose Poteligeo, often used for mycosis fungoides or Sézary syndrome — two types ...

Non-profit Race Against Blood Cancer recently launched an ... was diagnosed in April 2023 with folliculotropic mycosis fungoides, a rare and potentially aggressive type of cutaneous T-cell lymphoma.

The Saskatchewan government has agreed to a $40 million deal with Ottawa to improve access to medication for rare diseases ... for the treatment of mycosis fungoides or Sézary syndrome.

Takeda Canada Inc. (Takeda) is pleased to announce that Héma-Québec has added HyQvia®? (normal immunoglobulin [human] 10% and recombinant human hyaluronidase solution for subcutaneous infusion) as a ...

Although usually identified early, skin lymphomas can be mistaken for other skin conditions ... This type is similar to mycosis fungoides, but it also occurs in the blood and/or lymph nodes.

the first stage of funding will go toward three specific drugs under the National Strategy for Drugs for Rare Diseases: Poteligeo, for the treatment of mycosis fungoides or Sézary syndrome ...

The clinical study RW-HPN-MF-01, "Assessment of Treatment with Visible Light Activated Synthetic Hypericin Ointment in Mycosis Fungoides ... products to treat rare diseases where there is an ...

University Centre of General Dermatology and Oncodermatology, Faculty of Medicine, Wroclaw Medical University, Wroclaw, Poland Faculty of Medicine, Wroclaw University of Science and Technology, ...

Today, the Governments of Canada and the province of Saskatchewan signed the National Strategy for Drugs for Rare Disease (DRD ... treatment of adult patients with relapsed or refractory mycosis ...

Today, the Governments of Canada and the province of Ontario signed the National Strategy for Drugs for Rare Disease (DRD ... treatment of adult patients with relapsed or refractory mycosis fungoides ...